title: Treatment results of primary stage I and II non-Hodgkin's lymphoma of the stomach.
abstract: Gastric lymphoma in stage I or II was usually treated by partial gastrectomy and total abdominal irradiation in our institute since 1970. Since 1978, a number of patients were also treated without laparotomy, in clinical stage I with radiotherapy only and in clinical stage II with combined modality treatment. Treatment results of 58 patients are reported. A relapse-free survival rate of 85% was reached for 24 patients treated with resection and irradiation either in stage I or II, and for seven patients in stage I who did not undergo surgery. For these patients, survival in stage I was 85%, in stage II, however, survival dropped to 60% due to intercurrent deaths. Seven stage II2 patients received intensive chemotherapy and radiotherapy with 58% relapse-free survival. Twenty patients could not be treated according to the outlined treatment protocol. For the total group, survival in stage I is 65% and in stage II 35%. In the Addendum, an additional group of 17 patients is mentioned with the same result.
authors: The Netherlands Cancer Institute (Antoni van Leeuwenhoekhuis), Amsterdam.
authors: J M
authors: JM
authors: Burgers
authors: B G
authors: BG
authors: Taal
authors: P
authors: P
authors: van Heerde
authors: R
authors: R
authors: Somers
authors: F C
authors: FC
authors: den Hartog Jager
authors: A A
authors: AA
authors: Hart
mesh_terms: D000206:Actuarial Analysis; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D005743:Gastrectomy; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000401:mortality / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011879:Radiotherapy Dosage; D013274:Stomach Neoplasms / Q000401:mortality / Q000628:therapy*; D013997:Time Factors